Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 249 articles:
HTML format
Text format



Single Articles


    January 2017
  1. TRENADO C, Elben S, Friggemann L, Gruhn S, et al
    Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease.
    PLoS One. 2017;12:e0168151.
    PubMed     Text format     Abstract available


  2. RICCIARDI L, Visco-Comandini F, Erro R, Morgante F, et al
    Facial Emotion Recognition and Expression in Parkinson's Disease: An Emotional Mirror Mechanism?
    PLoS One. 2017;12:e0169110.
    PubMed     Text format     Abstract available


  3. JING H, Wang S, Wang M, Fu W, et al
    Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-kappaB Pathway.
    PLoS One. 2017;12:e0169560.
    PubMed     Text format     Abstract available


  4. YAMAMOTO T, Asahina M, Yamanaka Y, Uchiyama T, et al
    The Utility of Post-Void Residual Volume versus Sphincter Electromyography to Distinguish between Multiple System Atrophy and Parkinson's Disease.
    PLoS One. 2017;12:e0169405.
    PubMed     Text format     Abstract available


  5. STOTT SR, Hayat S, Carnwath T, Garas S, et al
    CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.
    PLoS One. 2017;12:e0171748.
    PubMed     Text format     Abstract available


  6. ZEISS CJ, Allore HG, Beck AP
    Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease.
    PLoS One. 2017;12:e0171790.
    PubMed     Text format     Abstract available


  7. PAUL R, Choudhury A, Kumar S, Giri A, et al
    Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    PLoS One. 2017;12:e0171285.
    PubMed     Text format     Abstract available


  8. CIESIELSKA A, Samaranch L, San Sebastian W, Dickson DW, et al
    Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    PLoS One. 2017;12:e0169965.
    PubMed     Text format     Abstract available



  9. Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-beta Generation and gamma-Secretase Activity.
    PLoS One. 2017;12:e0172775.
    PubMed     Text format     Abstract available


  10. VASTA R, Nicoletti A, Mostile G, Dibilio V, et al
    Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
    PLoS One. 2017;12:e0172145.
    PubMed     Text format     Abstract available


  11. CHAN RB, Perotte AJ, Zhou B, Liong C, et al
    Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis.
    PLoS One. 2017;12:e0172348.
    PubMed     Text format     Abstract available


  12. NACKAERTS E, Heremans E, Smits-Engelsman BC, Broeder S, et al
    Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson's disease.
    PLoS One. 2017;12:e0173157.
    PubMed     Text format     Abstract available


  13. LU J, Li X, Wang Q, Pei G, et al
    Dopamine D2 receptor and beta-arrestin 2 mediate Amyloid-beta elevation induced by anti-parkinson's disease drugs, levodopa and piribedil, in neuronal cells.
    PLoS One. 2017;12:e0173240.
    PubMed     Text format     Abstract available


  14. WESTPHAL R, Simmons C, Mesquita MB, Wood TC, et al
    Characterization of the resting-state brain network topology in the 6-hydroxydopamine rat model of Parkinson's disease.
    PLoS One. 2017;12:e0172394.
    PubMed     Text format     Abstract available


  15. WENG CC, Chen ZA, Chao KT, Ee TW, et al
    Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    PLoS One. 2017;12:e0173503.
    PubMed     Text format     Abstract available


  16. FUJIWARA M, Ding C, Kaunitz L, Stout JC, et al
    Optokinetic nystagmus reflects perceptual directions in the onset binocular rivalry in Parkinson's disease.
    PLoS One. 2017;12:e0173707.
    PubMed     Text format     Abstract available


  17. WEN M, Zhou B, Chen YH, Ma ZL, et al
    Serum uric acid levels in patients with Parkinson's disease: A meta-analysis.
    PLoS One. 2017;12:e0173731.
    PubMed     Text format     Abstract available


  18. HUERTAS I, Jesus S, Lojo JA, Garcia-Gomez FJ, et al
    Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    PLoS One. 2017;12:e0174644.
    PubMed     Text format     Abstract available


  19. YAN H, Wang J
    Quantification of motor network dynamics in Parkinson's disease by means of landscape and flux theory.
    PLoS One. 2017;12:e0174364.
    PubMed     Text format     Abstract available


  20. ROZANI V, Giladi N, El-Ad B, Gurevich T, et al
    Statin adherence and the risk of Parkinson's disease: A population-based cohort study.
    PLoS One. 2017;12:e0175054.
    PubMed     Text format     Abstract available


  21. TRENADO C, Elben S, Friggemann L, Gruhn S, et al
    Correction: Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease.
    PLoS One. 2017;12:e0175602.
    PubMed     Text format     Abstract available


  22. PATERNITI I, Campolo M, Siracusa R, Cordaro M, et al
    Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease.
    PLoS One. 2017;12:e0174470.
    PubMed     Text format     Abstract available


  23. PIERCE S, Coetzee GA
    Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
    PLoS One. 2017;12:e0175882.
    PubMed     Text format     Abstract available


  24. HUERTAS I, Jesus S, Garcia-Gomez FJ, Lojo JA, et al
    Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease.
    PLoS One. 2017;12:e0175560.
    PubMed     Text format     Abstract available


  25. FLORES ALVES DOS SANTOS J, Tezenas du Montcel S, Gargiulo M, Behar C, et al
    Tackling psychosocial maladjustment in Parkinson's disease patients following subthalamic deep-brain stimulation: A randomised clinical trial.
    PLoS One. 2017;12:e0174512.
    PubMed     Text format     Abstract available


  26. BUTCHER NJ, Merico D, Zarrei M, Ogura L, et al
    Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease.
    PLoS One. 2017;12:e0173944.
    PubMed     Text format     Abstract available


  27. ALKEMADE A, de Hollander G, Keuken MC, Schafer A, et al
    Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI.
    PLoS One. 2017;12:e0176130.
    PubMed     Text format     Abstract available



  28. Correction: Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    PLoS One. 2017;12:e0176628.
    PubMed     Text format     Abstract available


  29. ARTZI M, Even-Sapir E, Lerman Shacham H, Thaler A, et al
    DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers.
    PLoS One. 2017;12:e0175424.
    PubMed     Text format     Abstract available


  30. ALAM MN, Garg A, Munia TTK, Fazel-Rezai R, et al
    Vertical ground reaction force marker for Parkinson's disease.
    PLoS One. 2017;12:e0175951.
    PubMed     Text format     Abstract available


  31. MOONEN AJH, Weiss PH, Wiesing M, Weidner R, et al
    An fMRI study into emotional processing in Parkinson's disease: Does increased medial prefrontal activation compensate for striatal dysfunction?
    PLoS One. 2017;12:e0177085.
    PubMed     Text format     Abstract available


  32. ANGWIN AJ, Dissanayaka NNW, McMahon KL, Silburn PA, et al
    Lexical ambiguity resolution during sentence processing in Parkinson's disease: An event-related potential study.
    PLoS One. 2017;12:e0176281.
    PubMed     Text format     Abstract available


  33. CASPELL-GARCIA C, Simuni T, Tosun-Turgut D, Wu IW, et al
    Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.
    PLoS One. 2017;12:e0175674.
    PubMed     Text format     Abstract available


  34. BHATNAGAR M, Goel I, Roy T, Shukla SD, et al
    Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice.
    PLoS One. 2017;12:e0177254.
    PubMed     Text format     Abstract available


  35. GARCIA-MARTIN E, Pablo LE, Bambo MP, Alarcia R, et al
    Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson's disease.
    PLoS One. 2017;12:e0177163.
    PubMed     Text format     Abstract available


  36. AKHTAR RS, Xie SX, Chen YJ, Rick J, et al
    Regional brain amyloid-beta accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.
    PLoS One. 2017;12:e0177924.
    PubMed     Text format     Abstract available


  37. BETTECKEN K, Bernhard F, Sartor J, Hobert MA, et al
    No relevant association of kinematic gait parameters with Health-related Quality of Life in Parkinson's disease.
    PLoS One. 2017;12:e0176816.
    PubMed     Text format     Abstract available


  38. SAMOTUS O, Lee J, Jog M
    Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
    PLoS One. 2017;12:e0178670.
    PubMed     Text format     Abstract available


  39. HAYETE B, Wuest D, Laramie J, McDonagh P, et al
    A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease.
    PLoS One. 2017;12:e0178982.
    PubMed     Text format     Abstract available


  40. WANG L, Wang Z, Zhu R, Bi J, et al
    Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
    PLoS One. 2017;12:e0179476.
    PubMed     Text format     Abstract available


  41. TU XJ, Hwang WJ, Ma HI, Chang LH, et al
    Determinants of generic and specific health-related quality of life in patients with Parkinson's disease.
    PLoS One. 2017;12:e0178896.
    PubMed     Text format     Abstract available


  42. SHAHGHOLI L, De Jesus S, Wu SS, Pei Q, et al
    Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence.
    PLoS One. 2017;12:e0180425.
    PubMed     Text format     Abstract available


  43. KIM Y, Seok JM, Park J, Kim KH, et al
    The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism.
    PLoS One. 2017;12:e0180744.
    PubMed     Text format     Abstract available


  44. WU MC, Xu X, Chen SM, Tyan YS, et al
    Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.
    PLoS One. 2017;12:e0175836.
    PubMed     Text format     Abstract available


  45. MIKAMI K, Shiraishi M, Kawasaki T, Kamo T, et al
    Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position.
    PLoS One. 2017;12:e0181210.
    PubMed     Text format     Abstract available


  46. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Text format     Abstract available


  47. SCHWENKGRUB J, Zaremba M, Joniec-Maciejak I, Cudna A, et al
    The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease.
    PLoS One. 2017;12:e0182019.
    PubMed     Text format     Abstract available


  48. WU PL, Lee M, Huang TT
    Effectiveness of physical activity on patients with depression and Parkinson's disease: A systematic review.
    PLoS One. 2017;12:e0181515.
    PubMed     Text format     Abstract available


  49. NAPOLITANO F, Booth Warren E, Migliarini S, Punzo D, et al
    Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
    PLoS One. 2017;12:e0181677.
    PubMed     Text format     Abstract available


  50. MODO M, Crum WR, Gerwig M, Vernon AC, et al
    Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease.
    PLoS One. 2017;12:e0180733.
    PubMed     Text format     Abstract available


  51. LOPEZ A, Ortiz F, Doerrier C, Venegas C, et al
    Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
    PLoS One. 2017;12:e0183090.
    PubMed     Text format     Abstract available


  52. ERDOGDU SAKAR B, Serbes G, Sakar CO
    Analyzing the effectiveness of vocal features in early telediagnosis of Parkinson's disease.
    PLoS One. 2017;12:e0182428.
    PubMed     Text format     Abstract available


  53. KIM HW, Oh M, Oh JS, Oh SJ, et al
    Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
    PLoS One. 2017;12:e0169928.
    PubMed     Text format     Abstract available


  54. VELARDE OM, Mato G, Dellavale D
    Mechanisms for pattern specificity of deep-brain stimulation in Parkinson's disease.
    PLoS One. 2017;12:e0182884.
    PubMed     Text format     Abstract available


  55. CHEN CY, Hung HJ, Chang KH, Hsu CY, et al
    Long-term exposure to air pollution and the incidence of Parkinson's disease: A nested case-control study.
    PLoS One. 2017;12:e0182834.
    PubMed     Text format     Abstract available


    January 2016
  56. DE ROSE F, Marotta R, Poddighe S, Talani G, et al
    Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration.
    PLoS One. 2016;11:e0146140.
    PubMed     Text format     Abstract available


  57. MEDEIROS MS, Schumacher-Schuh A, Cardoso AM, Bochi GV, et al
    Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    PLoS One. 2016;11:e0146129.
    PubMed     Text format     Abstract available


  58. PRICE CC, Tanner J, Nguyen PT, Schwab NA, et al
    Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.
    PLoS One. 2016;11:e0147332.
    PubMed     Text format     Abstract available


  59. BERLYAND Y, Weintraub D, Xie SX, Mellis IA, et al
    An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.
    PLoS One. 2016;11:e0147319.
    PubMed     Text format     Abstract available


  60. HEREMANS E, Nackaerts E, Vervoort G, Broeder S, et al
    Impaired Retention of Motor Learning of Writing Skills in Patients with Parkinson's Disease with Freezing of Gait.
    PLoS One. 2016;11:e0148933.
    PubMed     Text format     Abstract available


  61. YAMAMOTO T, Tateno F, Sakakibara R, Furukawa S, et al
    Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
    PLoS One. 2016;11:e0149278.
    PubMed     Text format     Abstract available


  62. GAREA-RODRIGUEZ E, Eesmaa A, Lindholm P, Schlumbohm C, et al
    Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease.
    PLoS One. 2016;11:e0149776.
    PubMed     Text format     Abstract available


  63. LI J, Gu CZ, Su JB, Zhu LH, et al
    Changes in Olfactory Bulb Volume in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0149286.
    PubMed     Text format     Abstract available


  64. RAY CHAUDHURI K, Rojo JM, Schapira AH, Brooks DJ, et al
    Correction: A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need.
    PLoS One. 2016;11:e0150130.
    PubMed     Text format     Abstract available


  65. LIN IC, Wang YH, Wang TJ, Wang IJ, et al
    Correction: Glaucoma, Alzheimer's Disease, and Parkinson's Disease: An 8-Year Population-Based Follow-Up Study.
    PLoS One. 2016;11:e0150789.
    PubMed     Text format     Abstract available


  66. SHU Y, Ming J, Zhang P, Wang Q, et al
    Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity.
    PLoS One. 2016;11:e0149739.
    PubMed     Text format     Abstract available


  67. GERRITS NJ, van Loenhoud AC, van den Berg SF, Berendse HW, et al
    Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease.
    PLoS One. 2016;11:e0148852.
    PubMed     Text format     Abstract available


  68. PANOUILLERES MT, Tofaris GK, Brown P, Jenkinson N, et al
    Intact Acquisition and Short-Term Retention of Non-Motor Procedural Learning in Parkinson's Disease.
    PLoS One. 2016;11:e0149224.
    PubMed     Text format     Abstract available


  69. BERNHARD FP, Heinzel S, Binder G, Weber K, et al
    Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.
    PLoS One. 2016;11:e0150552.
    PubMed     Text format     Abstract available


  70. NORTON DJ, Nguyen VA, Lewis MF, Reynolds GO, et al
    Visuospatial Attention to Single and Multiple Objects Is Independently Impaired in Parkinson's Disease.
    PLoS One. 2016;11:e0150013.
    PubMed     Text format     Abstract available


  71. BROEN MP, Marsman VA, Kuijf ML, Van Oostenbrugge RJ, et al
    Unraveling the Relationship between Motor Symptoms, Affective States and Contextual Factors in Parkinson's Disease: A Feasibility Study of the Experience Sampling Method.
    PLoS One. 2016;11:e0151195.
    PubMed     Text format     Abstract available


  72. CRISPO JA, Willis AW, Thibault DP, Fortin Y, et al
    Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.
    PLoS One. 2016;11:e0150621.
    PubMed     Text format     Abstract available


  73. MAETZLER W, Deleersnijder W, Hanssens V, Bernard A, et al
    GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.
    PLoS One. 2016;11:e0149349.
    PubMed     Text format     Abstract available


  74. GIL-PRIETO R, Pascual-Garcia R, San-Roman-Montero J, Martinez-Martin P, et al
    Measuring the Burden of Hospitalization in Patients with Parkinson s Disease in Spain.
    PLoS One. 2016;11:e0151563.
    PubMed     Text format     Abstract available


  75. JOHNSON AR, Bucks RS, Kane RT, Thomas MG, et al
    Motor Subtype as a Predictor of Future Working Memory Performance in Idiopathic Parkinson's Disease.
    PLoS One. 2016;11:e0152534.
    PubMed     Text format     Abstract available


  76. VIVACQUA G, Latorre A, Suppa A, Nardi M, et al
    Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.
    PLoS One. 2016;11:e0151156.
    PubMed     Text format     Abstract available


  77. CONG L, Muir ER, Chen C, Qian Y, et al
    Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease.
    PLoS One. 2016;11:e0151884.
    PubMed     Text format     Abstract available


  78. VAN LUMMEL RC, Walgaard S, Hobert MA, Maetzler W, et al
    Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.
    PLoS One. 2016;11:e0151881.
    PubMed     Text format     Abstract available


  79. BAI S, Song Y, Huang X, Peng L, et al
    Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis.
    PLoS One. 2016;11:e0152564.
    PubMed     Text format     Abstract available


  80. VAN UEM JM, Walgaard S, Ainsworth E, Hasmann SE, et al
    Quantitative Timed-Up-and-Go Parameters in Relation to Cognitive Parameters and Health-Related Quality of Life in Mild-to-Moderate Parkinson's Disease.
    PLoS One. 2016;11:e0151997.
    PubMed     Text format     Abstract available


  81. BRECKENRIDGE CB, Berry C, Chang ET, Sielken RL Jr, et al
    Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0151841.
    PubMed     Text format     Abstract available


  82. HOPES L, Grolez G, Moreau C, Lopes R, et al
    Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?
    PLoS One. 2016;11:e0147947.
    PubMed     Text format     Abstract available


  83. LIU B, Chen H, Fang F, Tillander A, et al
    Early-Life Factors and Risk of Parkinson's Disease: A Register-Based Cohort Study.
    PLoS One. 2016;11:e0152841.
    PubMed     Text format     Abstract available


  84. TOMAS D, Stanic D, Chua HK, White K, et al
    Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's Disease.
    PLoS One. 2016;11:e0153424.
    PubMed     Text format     Abstract available


  85. TANG Y, Ge J, Liu F, Wu P, et al
    Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
    PLoS One. 2016;11:e0152716.
    PubMed     Text format     Abstract available


  86. CHIU PY, Tsai CT, Chen PK, Chen WJ, et al
    Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study.
    PLoS One. 2016;11:e0153989.
    PubMed     Text format     Abstract available


  87. SUWARNALATA G, Tan AH, Isa H, Gudimella R, et al
    Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater Severity.
    PLoS One. 2016;11:e0153725.
    PubMed     Text format     Abstract available


  88. MURTAZA M, Shan J, Matigian N, Todorovic M, et al
    Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease.
    PLoS One. 2016;11:e0154544.
    PubMed     Text format     Abstract available


  89. BAYLE N, Patel AS, Crisan D, Guo LJ, et al
    Contribution of Step Length to Increase Walking and Turning Speed as a Marker of Parkinson's Disease Progression.
    PLoS One. 2016;11:e0152469.
    PubMed     Text format     Abstract available


  90. HIGUCHI MA, Martinez-Ramirez D, Morita H, Topiol D, et al
    Interdisciplinary Parkinson's Disease Deep Brain Stimulation Screening and the Relationship to Unintended Hospitalizations and Quality of Life.
    PLoS One. 2016;11:e0153785.
    PubMed     Text format     Abstract available


  91. DE AZEVEDO AK, Claudino R, Conceicao JS, Swarowsky A, et al
    Anticipatory and Compensatory Postural Adjustments in Response to External Lateral Shoulder Perturbations in Subjects with Parkinson's Disease.
    PLoS One. 2016;11:e0155012.
    PubMed     Text format     Abstract available


  92. KAPOOR S, Shah MH, Singh N, Rather MI, et al
    Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex.
    PLoS One. 2016;11:e0155605.
    PubMed     Text format     Abstract available


  93. MOMCILOVIC O, Sivapatham R, Oron TR, Meyer M, et al
    Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
    PLoS One. 2016;11:e0154890.
    PubMed     Text format     Abstract available


  94. LEI H, Toosizadeh N, Schwenk M, Sherman S, et al
    A Pilot Clinical Trial to Objectively Assess the Efficacy of Electroacupuncture on Gait in Patients with Parkinson's Disease Using Body Worn Sensors.
    PLoS One. 2016;11:e0155613.
    PubMed     Text format     Abstract available


  95. UCHITOMI H, Ogawa KI, Orimo S, Wada Y, et al
    Effect of Interpersonal Interaction on Festinating Gait Rehabilitation in Patients with Parkinson's Disease.
    PLoS One. 2016;11:e0155540.
    PubMed     Text format     Abstract available


  96. WANG JW, Zhang YQ, Zhang XH, Wang YP, et al
    Cognitive and Psychiatric Effects of STN versus GPi Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0156721.
    PubMed     Text format     Abstract available


  97. BANERJEE M, Okun MS, Vaillancourt DE, Vemuri BC, et al
    A Method for Automated Classification of Parkinson's Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI.
    PLoS One. 2016;11:e0155764.
    PubMed     Text format     Abstract available


  98. DIPAOLA M, Pavan EE, Cattaneo A, Frazzitta G, et al
    Mechanical Energy Recovery during Walking in Patients with Parkinson Disease.
    PLoS One. 2016;11:e0156420.
    PubMed     Text format     Abstract available


  99. WEN Z, Zhang J, Li J, Dai J, et al
    Altered Activation in Cerebellum Contralateral to Unilateral Thalamotomy May Mediate Tremor Suppression in Parkinson's Disease: A Short-Term Regional Homogeneity fMRI Study.
    PLoS One. 2016;11:e0157562.
    PubMed     Text format     Abstract available


  100. MONTI DA, Zabrecky G, Kremens D, Liang TW, et al
    N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data.
    PLoS One. 2016;11:e0157602.
    PubMed     Text format     Abstract available


  101. SHI C, Zheng Z, Wang Q, Wang C, et al
    Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.
    PLoS One. 2016;11:e0155758.
    PubMed     Text format     Abstract available


  102. HONG JY, Sunwoo MK, Oh JS, Kim JS, et al
    Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging.
    PLoS One. 2016;11:e0157410.
    PubMed     Text format     Abstract available


  103. COUPLAND KG, Kim WS, Halliday GM, Hallupp M, et al
    Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.
    PLoS One. 2016;11:e0157924.
    PubMed     Text format     Abstract available


  104. PINHO R, Guedes LC, Soreq L, Lobo PP, et al
    Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.
    PLoS One. 2016;11:e0157852.
    PubMed     Text format     Abstract available


  105. VERVOORT G, Leunissen I, Firbank M, Heremans E, et al
    Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis.
    PLoS One. 2016;11:e0157743.
    PubMed     Text format     Abstract available


  106. SUROVA Y, Lampinen B, Nilsson M, Latt J, et al
    Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
    PLoS One. 2016;11:e0157755.
    PubMed     Text format     Abstract available


  107. SCHABRUN SM, Lamont RM, Brauer SG
    Transcranial Direct Current Stimulation to Enhance Dual-Task Gait Training in Parkinson's Disease: A Pilot RCT.
    PLoS One. 2016;11:e0158497.
    PubMed     Text format     Abstract available


  108. HARTMANN A, Mullner J, Meier N, Hesekamp H, et al
    Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.
    PLoS One. 2016;11:e0158235.
    PubMed     Text format     Abstract available


  109. SCHULTE EC, Altmaier E, Berger HS, Do KT, et al
    Alterations in Lipid and Inositol Metabolisms in Two Dopaminergic Disorders.
    PLoS One. 2016;11:e0147129.
    PubMed     Text format     Abstract available


  110. FENGLER S, Kessler J, Timmermann L, Zapf A, et al
    Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.
    PLoS One. 2016;11:e0159318.
    PubMed     Text format     Abstract available


  111. KASAI T, Tokuda T, Ohmichi T, Ishii R, et al
    Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy.
    PLoS One. 2016;11:e0147574.
    PubMed     Text format     Abstract available


  112. ARGAUD S, Delplanque S, Houvenaghel JF, Auffret M, et al
    Does Facial Amimia Impact the Recognition of Facial Emotions? An EMG Study in Parkinson's Disease.
    PLoS One. 2016;11:e0160329.
    PubMed     Text format     Abstract available


  113. LEE CY, Kang SJ, Hong SK, Ma HI, et al
    A Validation Study of a Smartphone-Based Finger Tapping Application for Quantitative Assessment of Bradykinesia in Parkinson's Disease.
    PLoS One. 2016;11:e0158852.
    PubMed     Text format     Abstract available


  114. VALENCA GT, Srivastava GP, Oliveira-Filho J, White CC, et al
    The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults.
    PLoS One. 2016;11:e0157452.
    PubMed     Text format     Abstract available


  115. FUNDAMENT T, Eldridge PR, Green AL, Whone AL, et al
    Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis.
    PLoS One. 2016;11:e0159340.
    PubMed     Text format     Abstract available


  116. ZHAO YZ, Jin RR, Yang W, Xiang Q, et al
    Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats.
    PLoS One. 2016;11:e0148848.
    PubMed     Text format     Abstract available


  117. YU Y, Wang K, Deng J, Sun M, et al
    Electroacupuncture Produces the Sustained Motor Improvement in 6-Hydroxydopamine-Lesioned Mice.
    PLoS One. 2016;11:e0149111.
    PubMed     Text format     Abstract available


  118. HUANG SF, Chen K, Wu JJ, Liu FT, et al
    Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China.
    PLoS One. 2016;11:e0160199.
    PubMed     Text format     Abstract available


  119. MIVILLE-GODBOUT E, Bourque M, Morissette M, Al-Sweidi S, et al
    Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice.
    PLoS One. 2016;11:e0151020.
    PubMed     Text format     Abstract available


  120. KAWAGUCHI H, Shimada H, Kodaka F, Suzuki M, et al
    Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
    PLoS One. 2016;11:e0151191.
    PubMed     Text format     Abstract available


  121. GAO L, Zhou W, Symmes B, Freed CR, et al
    Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease.
    PLoS One. 2016;11:e0160847.
    PubMed     Text format     Abstract available


  122. MATRONE C, Dzamko N, Madsen P, Nyegaard M, et al
    Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease.
    PLoS One. 2016;11:e0160501.
    PubMed     Text format     Abstract available


  123. NAGLE MW, Latourelle JC, Labadorf A, Dumitriu A, et al
    The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane.
    PLoS One. 2016;11:e0160925.
    PubMed     Text format     Abstract available


  124. DINOV ID, Heavner B, Tang M, Glusman G, et al
    Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    PLoS One. 2016;11:e0157077.
    PubMed     Text format     Abstract available


  125. LEE WW, Ehm G, Yang HJ, Song IH, et al
    Bilateral Deep Brain Stimulation of the Subthalamic Nucleus under Sedation with Propofol and Fentanyl.
    PLoS One. 2016;11:e0152619.
    PubMed     Text format     Abstract available


  126. WU YH, Lee WJ, Chen YH, Chang MH, et al
    Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study.
    PLoS One. 2016;11:e0161271.
    PubMed     Text format     Abstract available


  127. CHUNG SJ, Lee JJ, Ham JH, Ye BS, et al
    Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease.
    PLoS One. 2016;11:e0161316.
    PubMed     Text format     Abstract available


  128. BORONAT-GARCIA A, Palomero-Rivero M, Guerra-Crespo M, Millan-Aldaco D, et al
    Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease.
    PLoS One. 2016;11:e0160854.
    PubMed     Text format     Abstract available


  129. KROMER R, Buhmann C, Hidding U, Keseru M, et al
    Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography.
    PLoS One. 2016;11:e0161136.
    PubMed     Text format     Abstract available


  130. GEEVARGHESE R, Lumsden DE, Costello A, Hulse N, et al
    Verbal Memory Decline following DBS for Parkinson's Disease: Structural Volumetric MRI Relationships.
    PLoS One. 2016;11:e0160583.
    PubMed     Text format     Abstract available


  131. HAASUM Y, Fastbom J, Johnell K
    Use of Fall-Risk Inducing Drugs in Patients Using Anti-Parkinson Drugs (APD): A Swedish Register-Based Study.
    PLoS One. 2016;11:e0161246.
    PubMed     Text format     Abstract available


  132. SAULEAU P, Drapier S, Duprez J, Houvenaghel JF, et al
    Weight Gain following Pallidal Deep Brain Stimulation: A PET Study.
    PLoS One. 2016;11:e0153438.
    PubMed     Text format     Abstract available


  133. ODAGIRI H, Baba T, Nishio Y, Iizuka O, et al
    On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
    PLoS One. 2016;11:e0152746.
    PubMed     Text format     Abstract available


  134. KALILANI L, Asgharnejad M, Palokangas T, Durgin T, et al
    Comparing the Incidence of Falls/Fractures in Parkinson's Disease Patients in the US Population.
    PLoS One. 2016;11:e0161689.
    PubMed     Text format     Abstract available


  135. WEERNINK MG, van Til JA, van Vugt JP, Movig KL, et al
    Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease.
    PLoS One. 2016;11:e0160771.
    PubMed     Text format     Abstract available


  136. VONBERG I, Ehlen F, Fromm O, Kuhn AA, et al
    Deep Brain Stimulation of the Subthalamic Nucleus Improves Lexical Switching in Parkinsons Disease Patients.
    PLoS One. 2016;11:e0161404.
    PubMed     Text format     Abstract available


  137. WU CH, Tung YC, Lin TK, Chai CY, et al
    Hip Fracture in People with Erectile Dysfunction: A Nationwide Population-Based Cohort Study.
    PLoS One. 2016;11:e0153467.
    PubMed     Text format     Abstract available


  138. HARTMANN A, Muellner J, Meier N, Hesekamp H, et al
    Correction: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.
    PLoS One. 2016;11:e0162937.
    PubMed     Text format     Abstract available


  139. FRONTALINI F, Curzi D, Cesarini E, Canonico B, et al
    Mercury-Pollution Induction of Intracellular Lipid Accumulation and Lysosomal Compartment Amplification in the Benthic Foraminifer Ammonia parkinsoniana.
    PLoS One. 2016;11:e0162401.
    PubMed     Text format     Abstract available


  140. LU MK, Chen CM, Duann JR, Ziemann U, et al
    Investigation of Motor Cortical Plasticity and Corticospinal Tract Diffusion Tensor Imaging in Patients with Parkinsons Disease and Essential Tremor.
    PLoS One. 2016;11:e0162265.
    PubMed     Text format     Abstract available


  141. LANGKAMMER C, Pirpamer L, Seiler S, Deistung A, et al
    Quantitative Susceptibility Mapping in Parkinson's Disease.
    PLoS One. 2016;11:e0162460.
    PubMed     Text format     Abstract available


  142. YUAN J, Ren J, Wang Y, He X, et al
    Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease.
    PLoS One. 2016;11:e0162696.
    PubMed     Text format     Abstract available


  143. MUN JK, Youn J, Cho JW, Oh ES, et al
    Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naive Parkinson's Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study.
    PLoS One. 2016;11:e0162254.
    PubMed     Text format     Abstract available


  144. YANG W, Liu B, Huang B, Huang R, et al
    Altered Resting-State Functional Connectivity of the Striatum in Parkinson's Disease after Levodopa Administration.
    PLoS One. 2016;11:e0161935.
    PubMed     Text format     Abstract available


  145. MARIANI E, Frabetti F, Tarozzi A, Pelleri MC, et al
    Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.
    PLoS One. 2016;11:e0161567.
    PubMed     Text format     Abstract available


  146. ZHANG X, Ye YL, Zhu H, Sun SN, et al
    Selenotranscriptomic Analyses Identify Signature Selenoproteins in Brain Regions in a Mouse Model of Parkinson's Disease.
    PLoS One. 2016;11:e0163372.
    PubMed     Text format     Abstract available


  147. MOREAU C, Devos D, Baille G, Delval A, et al
    Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease?
    PLoS One. 2016;11:e0162904.
    PubMed     Text format     Abstract available


  148. ALMEIDA OP, McCaul K, Hankey GJ, Yeap BB, et al
    Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson's Disease.
    PLoS One. 2016;11:e0163781.
    PubMed     Text format     Abstract available


  149. DEWEY RB 3RD, O'Suilleabhain PE, Sanghera M, Patel N, et al
    Developing a Deep Brain Stimulation Neuromodulation Network for Parkinson Disease, Essential Tremor, and Dystonia: Report of a Quality Improvement Project.
    PLoS One. 2016;11:e0164154.
    PubMed     Text format     Abstract available


  150. DEAN DC 3RD, Sojkova J, Hurley S, Kecskemeti S, et al
    Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
    PLoS One. 2016;11:e0163774.
    PubMed     Text format     Abstract available


  151. WANG S, Zhang S, Xu C, Barron A, et al
    Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
    PLoS One. 2016;11:e0164465.
    PubMed     Text format     Abstract available


  152. SAN LUCIANO M, Wang C, Ortega RA, Yu Q, et al
    Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's Disease.
    PLoS One. 2016;11:e0162799.
    PubMed     Text format     Abstract available


  153. GAO R, Zhang G, Chen X, Yang A, et al
    CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.
    PLoS One. 2016;11:e0164762.
    PubMed     Text format     Abstract available


  154. YE R, Shen T, Jiang Y, Xu L, et al
    The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.
    PLoS One. 2016;11:e0164388.
    PubMed     Text format     Abstract available


  155. KIM D, Jeon H, Ryu S, Koo S, et al
    Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson's Disease Mouse Model.
    PLoS One. 2016;11:e0164906.
    PubMed     Text format     Abstract available


  156. MAKOVAC E, Cercignani M, Serra L, Torso M, et al
    Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic Form.
    PLoS One. 2016;11:e0163980.
    PubMed     Text format     Abstract available


  157. LOVEREIDE L, Hagell P
    Measuring Life Satisfaction in Parkinson's Disease and Healthy Controls Using the Satisfaction With Life Scale.
    PLoS One. 2016;11:e0163931.
    PubMed     Text format     Abstract available


  158. PETSCHOW C, Scheef L, Paus S, Zimmermann N, et al
    Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study.
    PLoS One. 2016;11:e0164607.
    PubMed     Text format     Abstract available


  159. FUJITA H, Suzuki K, Numao A, Watanabe Y, et al
    Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    PLoS One. 2016;11:e0165869.
    PubMed     Text format     Abstract available


  160. KRONIMUS Y, Albus A, Balzer-Geldsetzer M, Straub S, et al
    Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
    PLoS One. 2016;11:e0164953.
    PubMed     Text format     Abstract available


  161. ZHANG Y, Wu IW, Tosun D, Foster E, et al
    Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    PLoS One. 2016;11:e0165540.
    PubMed     Text format     Abstract available


  162. JAVOR A, Ransmayr G, Struhal W, Riedl R, et al
    Parkinson Patients' Initial Trust in Avatars: Theory and Evidence.
    PLoS One. 2016;11:e0165998.
    PubMed     Text format     Abstract available


  163. KOMNIG D, Imgrund S, Reich A, Grunder S, et al
    ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease.
    PLoS One. 2016;11:e0165235.
    PubMed     Text format     Abstract available


  164. LU J, Cui J, Li X, Wang X, et al
    An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-beta Generation and gamma-Secretase Activity.
    PLoS One. 2016;11:e0166415.
    PubMed     Text format     Abstract available


  165. HSU YC, Chang CW, Lee HL, Chuang CC, et al
    Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan.
    PLoS One. 2016;11:e0166552.
    PubMed     Text format     Abstract available


  166. KOPRICH JB, Johnston TH, Reyes G, Omana V, et al
    Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson's Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque.
    PLoS One. 2016;11:e0167235.
    PubMed     Text format     Abstract available


  167. LEE MJ, Son JS, Lee JH, Kim SJ, et al
    Impact of Prolonged Temporal Discrimination Threshold on Finger Movements of Parkinson's Disease.
    PLoS One. 2016;11:e0167034.
    PubMed     Text format     Abstract available


  168. JESUS S, Huertas I, Bernal-Bernal I, Bonilla-Toribio M, et al
    GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
    PLoS One. 2016;11:e0167749.
    PubMed     Text format     Abstract available


  169. BRYAN L, Kaye W, Antao V, Mehta P, et al
    Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    PLoS One. 2016;11:e0153683.
    PubMed     Text format     Abstract available


  170. KRUSE N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, et al
    A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    PLoS One. 2016;11:e0153564.
    PubMed     Text format     Abstract available


  171. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Text format     Abstract available


    January 2015
  172. ALTMANN LJ, Stegemoller E, Hazamy AA, Wilson JP, et al
    Unexpected dual task benefits on cycling in Parkinson disease and healthy adults: a neuro-behavioral model.
    PLoS One. 2015;10:e0125470.
    PubMed     Text format     Abstract available


  173. TODOROVIC M, Newman JR, Shan J, Bentley S, et al
    Comprehensive assessment of genetic sequence variants in the antioxidant 'master regulator' nrf2 in idiopathic Parkinson's disease.
    PLoS One. 2015;10:e0128030.
    PubMed     Text format     Abstract available


  174. BALASUBRAMANI PP, Chakravarthy VS, Ali M, Ravindran B, et al
    Identifying the Basal Ganglia Network Model Markers for Medication-Induced Impulsivity in Parkinson's Disease Patients.
    PLoS One. 2015;10:e0127542.
    PubMed     Text format     Abstract available


  175. LEV N, Barhum Y, Ben-Zur T, Aharony I, et al
    A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2.
    PLoS One. 2015;10:e0127549.
    PubMed     Text format     Abstract available


  176. HAN SW, Cheon KY, Kim JY, Baik JS, et al
    Carpal Tunnel Syndrome in Patients with Tremor Dominant Parkinson's Disease.
    PLoS One. 2015;10:e0130779.
    PubMed     Text format     Abstract available


  177. LABBE C, Ogaki K, Lorenzo-Betancor O, Carrasquillo MM, et al
    Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson's Disease Locus.
    PLoS One. 2015;10:e0128586.
    PubMed     Text format     Abstract available


  178. DIJKSTRA AA, Ingrassia A, de Menezes RX, van Kesteren RE, et al
    Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.
    PLoS One. 2015;10:e0128651.
    PubMed     Text format     Abstract available


  179. BRAHIM A, Ramirez J, Gorriz JM, Khedher L, et al
    Comparison between Different Intensity Normalization Methods in 123I-Ioflupane Imaging for the Automatic Detection of Parkinsonism.
    PLoS One. 2015;10:e0130274.
    PubMed     Text format     Abstract available


  180. LEE HJ, Kim SK, Park H, Kim HB, et al
    Clinicians' Tendencies to Under-Rate Parkinsonian Tremors in the Less Affected Hand.
    PLoS One. 2015;10:e0131703.
    PubMed     Text format     Abstract available


  181. ENRICI I, Adenzato M, Ardito RB, Mitkova A, et al
    Emotion Processing in Parkinson's Disease: A Three-Level Study on Recognition, Representation, and Regulation.
    PLoS One. 2015;10:e0131470.
    PubMed     Text format     Abstract available


  182. YANG X, Xi J, Zhao Q, Jia H, et al
    Association of the COQ2 V393A Variant with Parkinson's Disease: A Case-Control Study and Meta-Analysis.
    PLoS One. 2015;10:e0130970.
    PubMed     Text format     Abstract available


  183. BOCQUILLON P, Bourriez JL, Palmero-Soler E, Defebvre L, et al
    Impaired Early Attentional Processes in Parkinson's Disease: A High-Resolution Event-Related Potentials Study.
    PLoS One. 2015;10:e0131654.
    PubMed     Text format     Abstract available


  184. WANG YL, Wang YT, Li JF, Zhang YZ, et al
    Body Mass Index and Risk of Parkinson's Disease: A Dose-Response Meta-Analysis of Prospective Studies.
    PLoS One. 2015;10:e0131778.
    PubMed     Text format     Abstract available


  185. HU X, Song X, Li E, Liu J, et al
    Altered Resting-State Brain Activity and Connectivity in Depressed Parkinson's Disease.
    PLoS One. 2015;10:e0131133.
    PubMed     Text format     Abstract available


  186. ROEDER L, Costello JT, Smith SS, Stewart IB, et al
    Effects of Resistance Training on Measures of Muscular Strength in People with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0132135.
    PubMed     Text format     Abstract available


  187. PONT-SUNYER C, Iranzo A, Gaig C, Fernandez-Arcos A, et al
    Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers.
    PLoS One. 2015;10:e0132368.
    PubMed     Text format     Abstract available


  188. LUINSTRA M, Rutgers AW, Dijkstra H, Grasmeijer F, et al
    Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?
    PLoS One. 2015;10:e0132714.
    PubMed     Text format     Abstract available


  189. AUGUSTINE EF, Perez A, Dhall R, Umeh CC, et al
    Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.
    PLoS One. 2015;10:e0133002.
    PubMed     Text format     Abstract available


  190. BACH JP, Gold M, Mengel D, Hattesohl A, et al
    Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    PLoS One. 2015;10:e0132227.
    PubMed     Text format     Abstract available


  191. CHEN Y, Wei QQ, Ou R, Cao B, et al
    Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
    PLoS One. 2015;10:e0133776.
    PubMed     Text format     Abstract available


  192. TANNER JJ, Mareci TH, Okun MS, Bowers D, et al
    Temporal Lobe and Frontal-Subcortical Dissociations in Non-Demented Parkinson's Disease with Verbal Memory Impairment.
    PLoS One. 2015;10:e0133792.
    PubMed     Text format     Abstract available


  193. ZHU Z, Yuan D, Luo D, Lu X, et al
    Enrichment of Minor Alleles of Common SNPs and Improved Risk Prediction for Parkinson's Disease.
    PLoS One. 2015;10:e0133421.
    PubMed     Text format     Abstract available


  194. BRAHIM A, Ramirez J, Gorriz JM, Khedher L, et al
    Correction: Comparison between Different Intensity Normalization Methods in 123I-Ioflupane Imaging for the Automatic Detection of Parkinsonism.
    PLoS One. 2015;10:e0135107.
    PubMed     Text format     Abstract available


  195. DAN X, King BR, Doyon J, Chan P, et al
    Motor Sequence Learning and Consolidation in Unilateral De Novo Patients with Parkinson's Disease.
    PLoS One. 2015;10:e0134291.
    PubMed     Text format     Abstract available


  196. YOO HS, Yun HJ, Chung SJ, Sunwoo MK, et al
    Patterns of Neuropsychological Profile and Cortical Thinning in Parkinson's Disease with Punding.
    PLoS One. 2015;10:e0134468.
    PubMed     Text format     Abstract available


  197. SAWADA H, Oeda T, Umemura A, Tomita S, et al
    Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease.
    PLoS One. 2015;10:e0134118.
    PubMed     Text format     Abstract available


  198. GRUSCHUS JM
    Did alpha-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease.
    PLoS One. 2015;10:e0133863.
    PubMed     Text format     Abstract available


  199. WENNSTROM M, Surova Y, Hall S, Nilsson C, et al
    The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    PLoS One. 2015;10:e0135458.
    PubMed     Text format     Abstract available


  200. GRASHORN W, Schunke O, Buhmann C, Forkmann K, et al
    Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients.
    PLoS One. 2015;10:e0135287.
    PubMed     Text format     Abstract available


  201. LIU L, Xiong N, Zhang P, Chen C, et al
    Genetic Variants in GAPDH Confer Susceptibility to Sporadic Parkinson's Disease in a Chinese Han Population.
    PLoS One. 2015;10:e0135425.
    PubMed     Text format     Abstract available


  202. WABNEGGER A, Ille R, Schwingenschuh P, Katschnig-Winter P, et al
    Facial Emotion Recognition in Parkinson's Disease: An fMRI Investigation.
    PLoS One. 2015;10:e0136110.
    PubMed     Text format     Abstract available


  203. MCDONALD LM, Griffin HJ, Angeli A, Torkamani M, et al
    Motivational Modulation of Self-Initiated and Externally Triggered Movement Speed Induced by Threat of Shock: Experimental Evidence for Paradoxical Kinesis in Parkinson's Disease.
    PLoS One. 2015;10:e0135149.
    PubMed     Text format     Abstract available


  204. AL-MUBARAK BR, Bohlega SA, Alkhairallah TS, Magrashi AI, et al
    Parkinson's Disease in Saudi Patients: A Genetic Study.
    PLoS One. 2015;10:e0135950.
    PubMed     Text format     Abstract available


  205. VALKOVIC P, Minar M, Singliarova H, Harsany J, et al
    Pain in Parkinson s Disease: A Cross-Sectional Study of Its Prevalence, Types, and Relationship to Depression and Quality of Life.
    PLoS One. 2015;10:e0136541.
    PubMed     Text format     Abstract available


  206. UMEMURA A, Oeda T, Yamamoto K, Tomita S, et al
    Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease.
    PLoS One. 2015;10:e0136722.
    PubMed     Text format     Abstract available


  207. YANG Y, Tang BS, Weng L, Li N, et al
    Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism.
    PLoS One. 2015;10:e0136245.
    PubMed     Text format     Abstract available


  208. FERESHTEHNEJAD SM, Shafieesabet M, Farhadi F, Hadizadeh H, et al
    Heterogeneous Determinants of Quality of Life in Different Phenotypes of Parkinson's Disease.
    PLoS One. 2015;10:e0137081.
    PubMed     Text format     Abstract available


  209. NERO H, Benka Wallen M, Franzen E, Stahle A, et al
    Accelerometer Cut Points for Physical Activity Assessment of Older Adults with Parkinson's Disease.
    PLoS One. 2015;10:e0135899.
    PubMed     Text format     Abstract available


  210. CHEN X, Xie C, Sun L, Ding J, et al
    Longitudinal Metabolomics Profiling of Parkinson's Disease-Related alpha-Synuclein A53T Transgenic Mice.
    PLoS One. 2015;10:e0136612.
    PubMed     Text format     Abstract available


  211. SU X, Chu Y, Kordower JH, Li B, et al
    PGC-1alpha Promoter Methylation in Parkinson's Disease.
    PLoS One. 2015;10:e0134087.
    PubMed     Text format     Abstract available


  212. CAO R, Ye X, Chen X, Zhang L, et al
    Exploring Biological Motion Processing in Parkinson's Disease Using Temporal Dilation.
    PLoS One. 2015;10:e0138502.
    PubMed     Text format     Abstract available


  213. KOSHIMORI Y, Ko JH, Mizrahi R, Rusjan P, et al
    Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.
    PLoS One. 2015;10:e0138721.
    PubMed     Text format     Abstract available


  214. BERETTA VS, Gobbi LT, Lirani-Silva E, Simieli L, et al
    Challenging Postural Tasks Increase Asymmetry in Patients with Parkinson's Disease.
    PLoS One. 2015;10:e0137722.
    PubMed     Text format     Abstract available


  215. KONG Y, Liang X, Liu L, Zhang D, et al
    High Throughput Sequencing Identifies MicroRNAs Mediating alpha-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    PLoS One. 2015;10:e0137432.
    PubMed     Text format     Abstract available


  216. YAMAMOTO T, Uchiyama T, Higuchi Y, Asahina M, et al
    Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    PLoS One. 2015;10:e0138462.
    PubMed     Text format     Abstract available


  217. WEI L, Zhang J, Long Z, Wu GR, et al
    Correction: Reduced Topological Efficiency in Cortical-Basal Ganglia Motor Network of Parkinson's Disease: A Resting State fMRI Study.
    PLoS One. 2015;10:e0139757.
    PubMed     Text format     Abstract available



  218. Correction: Exploring Biological Motion Processing in Parkinson's Disease Using Temporal Dilation.
    PLoS One. 2015;10:e0140517.
    PubMed     Text format     Abstract available


  219. HOSKOVCOVA M, Dusek P, Sieger T, Brozova H, et al
    Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?
    PLoS One. 2015;10:e0139849.
    PubMed     Text format     Abstract available


  220. VAN KAMPEN JM, Baranowski DC, Robertson HA, Shaw CA, et al
    The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease.
    PLoS One. 2015;10:e0139694.
    PubMed     Text format     Abstract available


  221. HU Y, Yu SY, Zuo LJ, Piao YS, et al
    Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD.
    PLoS One. 2015;10:e0138997.
    PubMed     Text format     Abstract available


  222. QUATTROCCHI CC, de Pandis MF, Piervincenzi C, Galli M, et al
    Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study.
    PLoS One. 2015;10:e0137977.
    PubMed     Text format     Abstract available


  223. THOME AD, Standaert DG, Harms AS
    Fractalkine Signaling Regulates the Inflammatory Response in an alpha-Synuclein Model of Parkinson Disease.
    PLoS One. 2015;10:e0140566.
    PubMed     Text format     Abstract available


  224. OUESLATI A, Lovisa B, Perrin J, Wagnieres G, et al
    Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease.
    PLoS One. 2015;10:e0140880.
    PubMed     Text format     Abstract available


  225. SCHLENSTEDT C, Paschen S, Kruse A, Raethjen J, et al
    Resistance versus Balance Training to Improve Postural Control in Parkinson's Disease: A Randomized Rater Blinded Controlled Study.
    PLoS One. 2015;10:e0140584.
    PubMed     Text format     Abstract available


  226. HASEGAWA S, Goto S, Tsuji H, Okuno T, et al
    Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.
    PLoS One. 2015;10:e0142164.
    PubMed     Text format     Abstract available


  227. NILSSON M, Szczepankiewicz F, van Westen D, Hansson O, et al
    Extrapolation-Based References Improve Motion and Eddy-Current Correction of High B-Value DWI Data: Application in Parkinson's Disease Dementia.
    PLoS One. 2015;10:e0141825.
    PubMed     Text format     Abstract available


  228. ELLIS RJ, Ng YS, Zhu S, Tan DM, et al
    A Validated Smartphone-Based Assessment of Gait and Gait Variability in Parkinson's Disease.
    PLoS One. 2015;10:e0141694.
    PubMed     Text format     Abstract available


  229. SANG L, Zhang J, Wang L, Zhang J, et al
    Alteration of Brain Functional Networks in Early-Stage Parkinson's Disease: A Resting-State fMRI Study.
    PLoS One. 2015;10:e0141815.
    PubMed     Text format     Abstract available


  230. DIEZ-CIRARDA M, Ojeda N, Pena J, Cabrera-Zubizarreta A, et al
    Neuroanatomical Correlates of Theory of Mind Deficit in Parkinson's Disease: A Multimodal Imaging Study.
    PLoS One. 2015;10:e0142234.
    PubMed     Text format     Abstract available


  231. LI X, Li X, Li YX, Zhang Y, et al
    The Difference between Anxiolytic and Anxiogenic Effects Induced by Acute and Chronic Alcohol Exposure and Changes in Associative Learning and Memory Based on Color Preference and the Cause of Parkinson-Like Behaviors in Zebrafish.
    PLoS One. 2015;10:e0141134.
    PubMed     Text format     Abstract available



  232. Correction: Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?
    PLoS One. 2015;10:e0142765.
    PubMed     Text format     Abstract available


  233. HEREMANS E, Nackaerts E, Vervoort G, Vercruysse S, et al
    Amplitude Manipulation Evokes Upper Limb Freezing during Handwriting in Patients with Parkinson's Disease with Freezing of Gait.
    PLoS One. 2015;10:e0142874.
    PubMed     Text format     Abstract available


  234. MAURICE N, Deltheil T, Melon C, Degos B, et al
    Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease.
    PLoS One. 2015;10:e0142838.
    PubMed     Text format     Abstract available


  235. SANTIAGO JA, Potashkin JA
    Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.
    PLoS One. 2015;10:e0142582.
    PubMed     Text format     Abstract available


  236. KUMAR P, Segers-Nolten IM, Schilderink N, Subramaniam V, et al
    Parkinson's Protein alpha-Synuclein Binds Efficiently and with a Novel Conformation to Two Natural Membrane Mimics.
    PLoS One. 2015;10:e0142795.
    PubMed     Text format     Abstract available



  237. Correction: Neuroanatomical Correlates of Theory of Mind Deficit in Parkinson's Disease: A Multimodal Imaging Study.
    PLoS One. 2015;10:e0144482.
    PubMed     Text format     Abstract available


  238. SCHNEIDER JS, Seyfried TN, Choi HS, Kidd SK, et al
    Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.
    PLoS One. 2015;10:e0143351.
    PubMed     Text format     Abstract available


  239. LI DH, He YC, Quinn TJ, Liu J, et al
    Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naive Parkinson's Disease: A Meta-Analysis.
    PLoS One. 2015;10:e0144755.
    PubMed     Text format     Abstract available


  240. MARTINEZ-MARTIN P, Rodriguez-Blazquez C, Paz S, Forjaz MJ, et al
    Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis.
    PLoS One. 2015;10:e0145310.
    PubMed     Text format     Abstract available


  241. BECK EN, Ehgoetz Martens KA, Almeida QJ
    Freezing of Gait in Parkinson's Disease: An Overload Problem?
    PLoS One. 2015;10:e0144986.
    PubMed     Text format     Abstract available


  242. GARCIA-MIRALLES M, Coomaraswamy J, Habig K, Herzig MC, et al
    No dopamine cell loss or changes in cytoskeleton function in transgenic mice expressing physiological levels of wild type or G2019S mutant LRRK2 and in human fibroblasts.
    PLoS One. 2015;10:e0118947.
    PubMed     Text format     Abstract available


  243. MELZER TR, Myall DJ, MacAskill MR, Pitcher TL, et al
    Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease.
    PLoS One. 2015;10:e0143923.
    PubMed     Text format     Abstract available


  244. ESTERHAMMER R, Seppi K, Reiter E, Pinter B, et al
    Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
    PLoS One. 2015;10:e0145493.
    PubMed     Text format     Abstract available


  245. HUANG CK, Wu J, Cheng KY, Pan LK, et al
    Optimization of Imaging Parameters for SPECT scans of [99mTc]TRODAT-1 Using Taguchi Analysis.
    PLoS One. 2015;10:e0113817.
    PubMed     Text format     Abstract available


  246. DUINHOUWER LE, Tuysuz N, Rombouts EW, Ter Borg MN, et al
    Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.
    PLoS One. 2015;10:e0119086.
    PubMed     Text format     Abstract available


  247. KIM JS, Cho H, Choi JY, Lee SH, et al
    Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
    PLoS One. 2015;10:e0132585.
    PubMed     Text format     Abstract available


    January 2014
  248. ZHANG Z, Zhang Z, Wang H, Zhang G, et al
    Proliferating cell nuclear antigen binds DNA polymerase-beta and mediates 1-methyl-4-phenylpyridinium-induced neuronal death.
    PLoS One. 2014;9:e106669.
    PubMed     Text format     Abstract available


  249. PARSANEJAD M, Bourquard N, Qu D, Zhang Y, et al
    DJ-1 interacts with and regulates paraoxonase-2, an enzyme critical for neuronal survival in response to oxidative stress.
    PLoS One. 2014;9:e106601.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: